Clinical Trials Browser

Phase 1/2 × Melanoma × Interleukins × Clear all

NCT00553306 2017-02-15

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

Phase 1/2 Completed

Melanoma